Therapeutic Solutions International
Biotechnology company engaged in the development of products for females.
Launch date
Employees
Market cap
€3.5m
Enterprise valuation
€4m (Public information from Sep 2024)
Share price
$0.0008 TSOI
Oceanside California (HQ)
Financials
Estimates*
USD | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Revenues | - | - | <1m | <1m | <1m | <1m | <1m |
% growth | - | - | - | 128 % | 133 % | 42 % | (52 %) |
EBITDA | - | - | (1.0m) | (1.8m) | (2.3m) | (2.9m) | (1.7m) |
% EBITDA margin | - | - | (3770 %) | (2950 %) | (1566 %) | (1425 %) | (1692 %) |
Profit | - | - | (1.7m) | (2.2m) | (3.0m) | (3.7m) | (2.2m) |
% profit margin | - | - | (6173 %) | (3510 %) | (2029 %) | (1779 %) | (2192 %) |
EV / revenue | - | - | 207.5x | 241.2x | 466.1x | 81.1x | 47.1x |
EV / EBITDA | - | - | -5.5x | -8.2x | -29.8x | -5.7x | -2.8x |
R&D budget | - | - | <1m | <1m | <1m | 1.4m | <1m |
R&D % of revenue | - | - | 101 % | 897 % | 545 % | 697 % | 566 % |
Date | Investors | Amount | Round |
---|---|---|---|
N/A | N/A | IPO | |
N/A | $100k | Post IPO Equity | |
* | $500k | Post IPO Equity | |
* | $10.0m | Post IPO Equity | |
Total Funding | - |
Recent News about Therapeutic Solutions International
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.